PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RETINITIS PIGMENTOSA, COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS

摘要

The present invention relates to a pharmaceutical composition for preventing or treating retinitis pigmentosa, comprising mesenchymal stem cells derived from human embryonic stem cells. The mesenchymal stem cells derived from human embryonic stem cells, according to the present invention, increase the waveform of the b-wave reflecting inner nuclear layer activity, and exhibit an effect of protecting the cell nucleus of the outer nuclear layer of the retina. Thus, the mesenchymal stem cells derived from human embryonic stem cells of the present invention are expected to be usefully employed for the development of medicine or quasi-drugs for preventing, alleviating or treating inherited retinal diseases such as retinal cell degeneration.